主页文献库搜索
Distinct β-catenin and PIK3CA mutation profiles in endometriosis-associated o...

Matsumoto(Toshihide),Yamazaki(Masaaki),Tak... Am J Clin Pathol 2015-11-13

...PIK3CA mutations were observed in 11 (31.4%) of 35 OEMCas and 10 (35.7%) of 28 OCCCas. Ten of 11 OEMCas had PIK3CA mutat...

PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours.

Koren(Shany),Reavie(Linsey),Couto(Joana Pi... Nature 2015-10-01

...PIK3CA(H1047R) on mammary cell fate in the pre-neoplastic mammary gland and show that the cell of origin of PIK3CA(H1047...

Reactivation of multipotency by oncogenic PIK3CA induces breast tumour hetero...

Van Keymeulen(Alexandra),Lee(May Yin),Ouss... Nature 2015-10-01

...Pik3ca-derived tumours and the impact of mutations in this gene on tumour heterogeneity. Surprisingly, oncogenic Pik3ca(...

Model-Based Design of a Decision Tree for Treating HER2+ Cancers Based on Gen...

Kirouac(D C),Lahdenranta(J),Du(J),Yarar(D)... CPT Pharmacometrics Syst Ph... 2015-07-30

...PIK3CA and KRAS), and expression of the HER3 ligand heregulin determined sensitivity to combinations of inhibitors again...

Diagnostic yield of targeted next generation sequencing in various cancer typ...

Hagemann(Ian S),O'Neill(Patrick K),Erill(I... Cancer Genet 2015-11-17

...PIK3CA, KIT, BRAF, NRAS, IDH1, and JAK2. Sequencing results for each tumor were modeled as a dichotomized genotype (acti...

New and emerging factors in tumorigenesis: an overview.

Kim(Suwon) Cancer Manag Res 2015-08-07

...PIK3CA. Second, the mechanisms of resistance to targeted therapy are reviewed. These include acquired resistance under t...

Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of th...

Mendez(Pedro),Ramirez(Jose Luis) Transl Lung Cancer Res 2015-03-25

...PIK3CA, SOX2, ACK1, PRKCI, TP63, PLD1, ECT2, and others genes are located. Although SOX2 has been postulated as a key re...

Beyond conventional chemotherapy: Emerging molecular targeted and immunothera...

Ikeda(Sadakatsu),Hansel(Donna E),Kurzrock(... Cancer Treat Rev 2015-11-06

...PIK3CA, ERCC2, FGFR3, and HER2. Molecular targeted therapies against similar genetic alterations are currently available...

Preclinical evaluation of PI3K inhibitor BYL719 as a single agent and its syn...

Wong(Chi Hang),Ma(Brigette Buig Yue),Cheon... Am J Cancer Res 2015-06-23

Nasopharyngeal carcinoma (NPC) is endemic to Southeast Asia and over 40% of NPC tissues harbor PIK3CA amplifications. Th...

Analysis of circulating DNA and protein biomarkers to predict the clinical ac...

Tabernero(Josep),Lenz(Heinz-Josef),Siena(S... Lancet Oncol 2015-10-27

...PIK3CA wild-type; HR 0·54, 95% CI 0·32-0·89 for PIK3CA mutant [PIK3CA wild-type vs mutant, pinteraction=0·85]) or circul...

上一页 148 149 150 151 152 153 154 155 156 下一页 152 / 共 353

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com